Canada markets closed

SOHM, Inc. (SHMN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0014-0.0001 (-3.45%)
At close: 03:57PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0014
Open0.0014
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0012 - 0.0014
52 Week Range0.0005 - 0.0022
Volume3,783,089
Avg. Volume1,888,098
Market Cap1.076M
Beta (5Y Monthly)0.75
PE Ratio (TTM)N/A
EPS (TTM)-0.0020
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    SOHM, Inc. and Coastar Therapeutics Sign MoU and Announce Collaboration to Revolutionize Genome Editing Using Red Blood Cell Membrane Derived Carriers

    CHINO HILLS, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, announces today the collaboration with Coastar Therapeutics, San Diego, California, a leading biotechnology company specializing in innovative drug delivery systems, and SOHM, a cutting-edge biopharmaceutical company focused on gene editing technologies, are exc

  • GlobeNewswire

    SOHM Files Provisional Patent on ABBIE’s ‘Smart Gene-Editing’ That Uses Latest Enzymes and Guide RNA to Resolve Off-Target Gene-Editing Limitations

    CHINO HILLS, Calif., Jan. 09, 2024 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical, cosmeceutical and biotech Company that manufactures and markets generic drugs covering numerous treatment categories, announces today the Company has filed a provisional patent application on its ABBIE “Smart Gene-Editing” platform that uses the latest enzymes and guide RNAs to resolve off-target gene-editing limitations. Gene-editing Market The gene-edi

  • GlobeNewswire

    SOHM Announces Business Outlook for 2024

    CHINO HILLS, Calif., Dec. 05, 2023 (GLOBE NEWSWIRE) -- via IBN -- SOHM, Inc. (OTC PINK: SHMN) (the “Company”), a pharmaceutical, nutraceutical and cosmeceutical Company that manufactures and markets generic drugs covering numerous treatment categories, announced: SOHM Announces Business Outlook for 2024 for each of its Business Units. SOHM, Inc. is organized into the following business units: -- OTC Self-care (over-the-counter nutraceuticals and cosmeceuticals) -- Branded Generics (off-patent pr